Efficacy and cost-effectiveness of two online interventions for children and adolescents at risk for depression (E.motion trial): study protocol for a randomized controlled trial within the ProHEAD consortium.
Adolescent
Adolescent Behavior
Affect
Age Factors
Child
Child Behavior
Cost-Benefit Analysis
Depression
/ diagnosis
Germany
Health Care Costs
Humans
Internet
/ economics
Multicenter Studies as Topic
Patient Health Questionnaire
Randomized Controlled Trials as Topic
Self Care
Telemedicine
/ economics
Therapy, Computer-Assisted
/ economics
Time Factors
Treatment Outcome
Adolescence
Adolescents
Children
Depression
Depressive symptoms
Internet-based
Prevention
ProHEAD
Psychological intervention
Self-management
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
15 Jan 2019
15 Jan 2019
Historique:
received:
02
07
2018
accepted:
22
12
2018
entrez:
17
1
2019
pubmed:
17
1
2019
medline:
8
5
2019
Statut:
epublish
Résumé
Depression is a serious mental health problem and is common in children and adolescents. Online interventions are promising in overcoming the widespread undertreatment of depression and in improving the help-seeking behavior in children and adolescents. The multicentre, randomized controlled E.motion trial is part of the German ProHEAD consortium (Promoting Help-seeking using E-technology for ADolescents). The objective of the trial is to investigate the efficacy and cost-effectiveness of two online interventions to reduce depressive symptomatology in high-risk children and adolescents with subsyndromal symptoms of depression in comparison to an active control group. Participants will be randomized to one of three conditions: (1) Intervention 1, a clinician-guided self-management program (iFightDepression®); (2) Intervention 2, a clinician-guided group chat intervention; and (3) Control intervention, a psycho-educational website on depressive symptoms. Interventions last six weeks. In total, N = 363 children and adolescents aged ≥ 12 years with Patient Health Questionnaire-9 modified for Adolescents (PHQ-A) scores in the range of 5-9 will be recruited at five study sites across Germany. Online questionnaires will be administered before onset of the intervention, at the end of the intervention, and at the six-month follow-up. Further, children and adolescents will participate in the baseline screening and the one- and two-year school-based follow-up assessments integrated in the ProHEAD consortium. The primary endpoint is depression symptomatology at the end of intervention as measured by the PHQ-A score. Secondary outcomes include depression symptomatology at all follow-ups, help-seeking attitudes, and actual face-to-face help-seeking, adherence to and satisfaction with the interventions, depression stigma, and utilization and cost of interventions. This study represents the first randomized controlled trial (RCT) investigating efficacy and cost-effectiveness of two online interventions in children and adolescents aged ≥ 12 years at risk for depression. It aims to provide a better understanding of the help-seeking behavior of children and adolescents, potential benefits of E-mental health interventions for this age group, and new insights into so far understudied aspects of E-mental health programs, such as potential negative effects of online interventions. This knowledge will be used to tailor and improve future help offers and programs for children and adolescents and ways of treatment allocation. German Register for Clinical Trials (DRKS), DRKS00014668 . Registered on 4 May 2018. International trial registration took place through the "international clinical trials registry platform" with the secondary ID S-086/2018.
Sections du résumé
BACKGROUND
BACKGROUND
Depression is a serious mental health problem and is common in children and adolescents. Online interventions are promising in overcoming the widespread undertreatment of depression and in improving the help-seeking behavior in children and adolescents.
METHODS
METHODS
The multicentre, randomized controlled E.motion trial is part of the German ProHEAD consortium (Promoting Help-seeking using E-technology for ADolescents). The objective of the trial is to investigate the efficacy and cost-effectiveness of two online interventions to reduce depressive symptomatology in high-risk children and adolescents with subsyndromal symptoms of depression in comparison to an active control group. Participants will be randomized to one of three conditions: (1) Intervention 1, a clinician-guided self-management program (iFightDepression®); (2) Intervention 2, a clinician-guided group chat intervention; and (3) Control intervention, a psycho-educational website on depressive symptoms. Interventions last six weeks. In total, N = 363 children and adolescents aged ≥ 12 years with Patient Health Questionnaire-9 modified for Adolescents (PHQ-A) scores in the range of 5-9 will be recruited at five study sites across Germany. Online questionnaires will be administered before onset of the intervention, at the end of the intervention, and at the six-month follow-up. Further, children and adolescents will participate in the baseline screening and the one- and two-year school-based follow-up assessments integrated in the ProHEAD consortium. The primary endpoint is depression symptomatology at the end of intervention as measured by the PHQ-A score. Secondary outcomes include depression symptomatology at all follow-ups, help-seeking attitudes, and actual face-to-face help-seeking, adherence to and satisfaction with the interventions, depression stigma, and utilization and cost of interventions.
DISCUSSION
CONCLUSIONS
This study represents the first randomized controlled trial (RCT) investigating efficacy and cost-effectiveness of two online interventions in children and adolescents aged ≥ 12 years at risk for depression. It aims to provide a better understanding of the help-seeking behavior of children and adolescents, potential benefits of E-mental health interventions for this age group, and new insights into so far understudied aspects of E-mental health programs, such as potential negative effects of online interventions. This knowledge will be used to tailor and improve future help offers and programs for children and adolescents and ways of treatment allocation.
TRIAL REGISTRATION
BACKGROUND
German Register for Clinical Trials (DRKS), DRKS00014668 . Registered on 4 May 2018. International trial registration took place through the "international clinical trials registry platform" with the secondary ID S-086/2018.
Identifiants
pubmed: 30646944
doi: 10.1186/s13063-018-3156-8
pii: 10.1186/s13063-018-3156-8
pmc: PMC6334409
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
53Subventions
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1744E
Investigateurs
Michael Kaess
(M)
Stephanie Bauer
(S)
Rainer Thomasius
(R)
Christine Rummel-Kluge
(C)
Heike Eschenbeck
(H)
Hans-Joachim Salize
(HJ)
Katja Becker
(K)
Katja Bertsch
(K)
Sally Bilic
(S)
Romuald Brunner
(R)
Johannes Feldhege
(J)
Christina Gallinat
(C)
Sabine C Herpertz
(SC)
Julian Koenig
(J)
Sophia Lustig
(S)
Markus Moessner
(M)
Fikret Özer
(F)
Peter Parzer
(P)
Franz Resch
(F)
Sabrina Ritter
(S)
Jens Spinner
(J)
Silke Diestelkamp
(S)
Kristina Wille
(K)
Sabrina Baldofski
(S)
Elisabeth Kohls
(E)
Lina-Jolien Peter
(LJ)
Vera Gillé
(V)
Hanna Hofmann
(H)
Laya Lehner
(L)
Elke Voß
(E)
Jens Pfeiffer
(J)
Alisa Samel
(A)
Références
Can J Psychiatry. 2013 Jul;58(7):376-85
pubmed: 23870719
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
J Am Acad Child Adolesc Psychiatry. 2015 Jan;54(1):37-44.e2
pubmed: 25524788
Trials. 2019 Jan 22;20(1):73
pubmed: 30670102
Qual Life Res. 2010 Dec;19(10):1487-500
pubmed: 20668950
Trials. 2019 Jan 30;20(1):91
pubmed: 30700318
J Adolesc Health. 2002 Mar;30(3):196-204
pubmed: 11869927
Adolesc Health Med Ther. 2010 Aug 11;1:87-95
pubmed: 24600264
Depress Anxiety. 2017 Jul;34(7):596-602
pubmed: 28471479
Child Adolesc Psychiatr Clin N Am. 2011 Apr;20(2):191-204
pubmed: 21440850
Patient Educ Couns. 2008 Mar;70(3):357-62
pubmed: 18077123
Expert Rev Pharmacoecon Outcomes Res. 2005 Jun;5(3):353-64
pubmed: 19807604
J Child Psychol Psychiatry. 2006 Dec;47(12):1263-71
pubmed: 17176381
Br J Psychiatry. 2004 Oct;185:342-9
pubmed: 15458995
Clin Trials. 2012 Aug;9(4):396-407
pubmed: 22752633
Cochrane Database Syst Rev. 2011 Dec 07;(12):CD003380
pubmed: 22161377
Can J Psychiatry. 2003 Mar;48(2):115-24
pubmed: 12655910
J Med Internet Res. 2012 Jun 07;14(3):e86
pubmed: 22677437
Depress Anxiety. 2009;26(1):65-72
pubmed: 18828141
Trials. 2019 Jan 31;20(1):94
pubmed: 30704534
J Med Internet Res. 2017 Jul 24;19(7):e262
pubmed: 28739561
Aging Ment Health. 2007 Jan;11(1):69-74
pubmed: 17164160
Trials. 2019 Jan 18;20(1):64
pubmed: 30658675
J Clin Psychiatry. 2005 Dec;66(12):1580-5
pubmed: 16401161
Child Adolesc Psychiatr Clin N Am. 2016 Apr;25(2):201-18
pubmed: 26980124
Br J Psychiatry. 2007 Oct;191:335-42
pubmed: 17906244
Soc Sci Med. 1994 Aug;39(4):563-72
pubmed: 7973856
JMIR Res Protoc. 2015 Aug 06;4(3):e99
pubmed: 26251104
J Obstet Gynecol Neonatal Nurs. 2003 Mar-Apr;32(2):239-48
pubmed: 12685676
J Affect Disord. 2004 Jul;81(1):61-6
pubmed: 15183601
J Med Internet Res. 2018 Apr 03;20(4):e120
pubmed: 29615385
Arch Intern Med. 2009 Feb 9;169(3):230-5; discussion 235-6
pubmed: 19204212
J Child Psychol Psychiatry. 2015 Mar;56(3):345-65
pubmed: 25649325
Br J Psychiatry. 2010 Oct;197(4):297-304
pubmed: 20884953
Z Kinder Jugendpsychiatr Psychother. 2012 Nov;40(6):399-404
pubmed: 23109128
J Affect Disord. 2017 Mar 01;210:22-26
pubmed: 28012349
BMC Psychiatry. 2010 Dec 30;10:113
pubmed: 21192795
J Affect Disord. 2012 Feb;136(3):393-7
pubmed: 22137765
J Child Adolesc Psychopharmacol. 2016 Apr;26(3):235-45
pubmed: 26465266
J Med Internet Res. 2014 May 29;16(5):e141
pubmed: 24874006
Eur Child Adolesc Psychiatry. 2013 Oct;22(10):589-603
pubmed: 23579389
Early Interv Psychiatry. 2015 Dec;9(6):498-506
pubmed: 24684927
Psychother Psychosom Med Psychol. 1989 Jul;39(7):248-55
pubmed: 2762479
J Affect Disord. 2004 Feb;78(2):131-40
pubmed: 14706723
Z Kinder Jugendpsychiatr Psychother. 2009 Sep;37(5):451-9
pubmed: 19739063
Cochrane Database Syst Rev. 2004;(1):CD003380
pubmed: 14974014
J Am Acad Child Adolesc Psychiatry. 1996 Nov;35(11):1427-39
pubmed: 8936909
PLoS One. 2015 May 14;10(5):e0125527
pubmed: 25974146
Eur Child Adolesc Psychiatry. 1998 Sep;7(3):125-30
pubmed: 9826298
BMC Psychiatry. 2017 Apr 19;17(1):143
pubmed: 28420367
J Consult Clin Psychol. 1996 Oct;64(5):936-40
pubmed: 8916622
BMC Complement Altern Med. 2015 Dec 24;15:450
pubmed: 26702639